Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: Post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)

Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, Luca Porcu, A. Grothey, Alfredo Falcone, Eric Van Cutsem, Guillem Argilés, Antoine Adenis, Marc Ychou, Carlo Barone, Olivier Bouché, Marc Peeters, Yves Humblet, Laurent Mineur, Alberto F. Sobrero, Joleen M. Hubbard, Chiara Cremolini, Hans Prenen, Josep TaberneroHajer Jarraya, Thibault Mazard, Sophie Deguelte-Lardiere, Konstantinos Papadimitriou, Marc Van Den Eynde, Alessandro Pastorino, Daniela Redaelli, Katia Bencardino, Chiara Funaioli, Alessio Amatu, Giulia Carlo-Stella, Valter Torri, Andrea Sartore-Bianchi, Angelo Vanzulli, Salvatore Siena

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: Post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)'. Together they form a unique fingerprint.

Medicine & Life Sciences